Paul Diehl BA, PhD

Dr. Paul Diehl joined Cellecta, Inc. in July 2010 where he applies his 19 years of experience in commercial biotechnology and formal background in biochemistry and molecular biology to developing and expanding the company’s commercial and collaborative partnerships and interactions. Prior to joining Cellecta, Dr. Diehl held various marketing and business development positions related to developing, launching, and supporting research focused life science products and technology at B-Bridge International, Arcturus Bioscience, Agilent Laboratories, Display Systems Biotech, and Clontech Laboratories. Dr. Diehl received his B.A. in Biology from LaSalle University in Philadelphia in 1988 and his Ph.D. in Biochemistry from Washington State University in Pullman, WA in 1993. As a graduate student he analyzed the activity of E. coli isocitrate lyase using site-directed mutagenesis.